Get the Stockscreener App
47.80
1.81%
0.85
After Hours:
47.82
0.02
+0.04%
Boston Scientific Corp stock is traded at $47.80, with a volume of 15.44M.
It is up +1.81% in the last 24 hours and down -2.63% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$46.95
Open:
$46.92
24h Volume:
15.44M
Relative Volume:
0.78
Market Cap:
$69.27B
Revenue:
$20.62B
Net Income/Loss:
$3.56B
P/E Ratio:
20.04
EPS:
2.3847
Net Cash Flow:
$3.48B
1W Performance:
+2.05%
1M Performance:
-2.63%
6M Performance:
-33.80%
1Y Performance:
-55.45%
1-Day Range:
$46.83
$48.06
1-Week Range:
$46.09
$49.66
52-Week Range:
$42.20
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-26 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
Boston Scientific stock gains support from institutional buying and solid Q2 2026 results - AD HOC NEWS
Update on recent cybersecurity incident - Boston Scientific
Recall Recap: Boston Scientific Pacemakers, Baby Formula - law360.com
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk - Benzinga
Renal Denervation Market Size, Share & Trends Analysis - GlobeNewswire Inc.
Boston Scientific (NYSE:BSX) Trades Below Its Cash-Flow Value - Kalkine Media
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Vanguard PRIMECAP Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (NYSE:BSX) Closes In on Its Landmark Penumbra Deal - Kalkine Media
How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - Barchart.com
Boston Scientific (NYSE: BSX) EVP’s 1,171-share award partly withheld for taxes - Stock Titan
Boston Scientific options surge signals institutional bet on year-end recovery - Investing.com
Healthcare cyberattacks hit pacemakers and millions of patient records - theregister.com
Is It Too Late to Buy Boston Scientific Corp (BSX) After 3.1% Ra - GuruFocus
Boston Scientific Working to Restore Shipments After Cyberattack - marketscreener.com
Boston Scientific faces ongoing operational disruption after cybersecurity incident impacts IT systems, order processing - industrialcyber.co
Boston Scientific Corp (BSX) Insider Susan Morano Buys 2,040 Sha - GuruFocus
Boston Scientific director Susan Morano buys $100,407 in shares - Investing.com
Boston Scientific (BSX) Faces Disruption from Cyber Attack - GuruFocus
Boston Scientific Targeted in Cyberattack - Medical Product Outsourcing
Boston Scientific reports global IT disruption from cybersecurity incident, shipment delays possible - TradingView
Boston Scientific Says Cyberattack Disrupting Global Operations -- Update - marketscreener.com
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Boston Scientific stock holds steady as institutional buyers build positions - Ad-hoc-news.de
Boston Scientific (NYSE:BSX) Gains Focus After Healthcare Shift - Kalkine Media
BSX|Boston Scientific Corp|Price:49.740|Chg%:+0.370 - TradingKey
Edmond DE Rothschild Holding S.A. Acquires Shares of 875,810 Boston Scientific Corporation $BSX - MarketBeat
A Look at Boston Scientific Corp (BSX) After 3.0% Gain -- GF Val - GuruFocus
Boston Scientific stock trades around $50 as Q2 2026 margins and earnings expand - AD HOC NEWS
Great Lakes Advisors LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific stock holds in the low $51 range as Q2 2026 margins and EPS beat guidance - AD HOC NEWS
Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks - AboutLawsuits.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises - Yahoo Finance
Boston Scientific stock extends 7-day rebound as Q2 2026 margins expand - AD HOC NEWS
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Looks Cheap On Earnings And Fair Value - simplywall.st
Congress Large Cap Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - Yahoo Finance
Fidelity Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Union Bancaire Privee UBP SA Sells 173,105 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Boston Scientific Corp Stock (BSX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Habiger David C | Director |
Aug 05 '26 |
Buy |
47.59 |
2,100 |
99,937 |
17,160 |
| Habiger David C | Director |
Aug 03 '26 |
Buy |
48.07 |
1,042 |
50,084 |
14,920 |
| Habiger David C | Director |
Aug 04 '26 |
Buy |
48.59 |
140 |
6,802 |
15,060 |
| Mahoney Michael F | Chairman, President & CEO |
Aug 03 '26 |
Buy |
48.33 |
186,240 |
9,001,408 |
1,590,024 |
| LUDWIG EDWARD J | Director |
Jul 31 '26 |
Buy |
45.48 |
5,000 |
227,400 |
30,359 |
| Monson Jonathan | EVP and CFO |
Jul 01 '26 |
Option Exercise |
0.00 |
2,087 |
0 |
40,073 |
| Pegus Cheryl | Director |
May 20 '26 |
Buy |
56.49 |
1,770 |
99,987 |
1,770 |
| LUDWIG EDWARD J | Director |
May 20 '26 |
Buy |
56.68 |
3,580 |
202,914 |
25,359 |
| Habiger David C | Director |
May 20 '26 |
Buy |
55.92 |
2,250 |
125,819 |
13,878 |
| Habiger David C | Director |
May 19 '26 |
Buy |
56.95 |
2,200 |
125,279 |
11,628 |
0.13%
2.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):